Cargando…

Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China

BACKGROUND: To evaluate the expression and differential diagnostic significance of CK19, TG, Ki67 and galectin-3 in papillary thyroid carcinoma (PTC) (metastatic and non metastatic), follicular adenoma and nodular goiter in patients from the northeastern part of China. METHODS: 441 PTC specimens and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Qingbin, Wang, Deguang, Lou, Yi, Li, Changsi, Fang, Changqing, He, Xiangmin, Li, Jianhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264507/ https://www.ncbi.nlm.nih.gov/pubmed/22188859 http://dx.doi.org/10.1186/1746-1596-6-126

Ejemplares similares

Diagnostic significance of CK19, galectin-3, CD56, TPO and Ki67 expression and BRAF mutation in papillary thyroid carcinoma
por: Huang, Lihua, et al.
Publicado: (2018)

Ki-67 and CK-19 are predictors of locoregional recurrence in papillary thyroid carcinoma
por: Viana, Aline de Oliveira Ribeiro, et al.
Publicado: (2020)

The clinicopathological significance of Ki67 in papillary thyroid carcinoma: a suitable indicator?
por: Tang, Jingdong, et al.
Publicado: (2018)

The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer
por: Lindfors, Helene, et al.
Publicado: (2021)

Invited Commentary: The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer
por: Barczyński, Marcin
Publicado: (2021)

Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer
por: Lindfors, Helene, et al.
Publicado: (2023)

The influence of thyroid status, serum Tg, TSH, and TgAb on FNA‐Tg in cervical metastatic lymph nodes of papillary thyroid carcinoma
por: Sun, Jingjing, et al.
Publicado: (2021)

ER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer—Reduced CK5 Expression in Metastases
por: Joensuu, Kristiina, et al.
Publicado: (2013)

Evaluation of Ki67, p16 and CK17 Markers in Differentiating Cervical Intraepithelial Neoplasia and Benign Lesions
por: Sari Aslani, Fatemeh, et al.
Publicado: (2013)

Predictive Value of FNA-Tg and TgAb in Cervical Lymph Node Metastasis of Papillary Thyroid Carcinoma
por: Wu, Xiaoli, et al.
Publicado: (2022)

The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer
por: Adamo, Barbara, et al.
Publicado: (2017)

The Ki67 index a prognostic marker in medullary thyroid carcinoma
por: Tisell, L E, et al.
Publicado: (2003)

TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors
por: Matsuse, Michiko, et al.
Publicado: (2017)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer
por: Adamo, Barbara, et al.
Publicado: (2019)

Diagnostic and Prognostic Implications of FGFR3(high)/Ki67(high) Papillary Bladder Cancers
por: Geelvink, Mirja, et al.
Publicado: (2018)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Combination of galectin-3, CK19 and HBME-1 immunostaining improves the diagnosis of thyroid cancer
por: Arcolia, Vanessa, et al.
Publicado: (2017)

The Value of Ki-67 Labeling Index in Central Lymph Node Metastasis and Survival of Papillary Thyroid Carcinoma: Evidence From the Clinical and Molecular Analyses
por: Lei, Yi, et al.
Publicado: (2023)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Clinical Significance of Ki-67 Labeling Index in Pituitary Macroadenoma
por: Paek, Kyung-Il, et al.
Publicado: (2005)

Significance of p53 and ki-67 expression in prostate cancer
por: Verma, Renuka, et al.
Publicado: (2015)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Pre-Therapeutic Measurements of Iodine Avidity in Papillary and Poorly Differentiated Thyroid Cancer Reveal Associations with Thyroglobulin Expression, Histological Variants and Ki-67 Index
por: Nilsson, Joachim N., et al.
Publicado: (2021)

The nucleolar protein NIFK promotes cancer progression via CK1α/β-catenin in metastasis and Ki-67-dependent cell proliferation
por: Lin, Tsung-Chieh, et al.
Publicado: (2016)

Partial Oxygen Pressure Affects the Expression of Prognostic Biomarkers HIF-1 Alpha, Ki67, and CK20 in the Microenvironment of Colorectal Cancer Tissue
por: Zhang, Lirong, et al.
Publicado: (2016)

Differential diagnosis of urothelial carcinoma in situ from non-neoplastic urothelia: Analysis of CK20, CD44, P53 and Ki67
por: Asgari, Mojgan, et al.
Publicado: (2016)

Role of Maspin, CK17 and Ki-67 Immunophenotyping in Diagnosing of Pancreatic Ductal Adenocarcinoma in Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology
por: Mamdouh, Mona M, et al.
Publicado: (2021)

Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer
por: Yuan, Jing Ping, et al.
Publicado: (2015)

A retrospective study on expression and clinical significance of PHH3, Ki67 and P53 in bladder exophytic papillary urothelial neoplasms
por: Qi, Gaoxiu, et al.
Publicado: (2023)

Clinical impact of thyroglobulin (Tg) and Tg autoantibody (TgAb) measurements in needle washouts of neck lymph node biopsies in the management of patients with papillary thyroid carcinoma
por: Martins-Costa, M. Cecilia, et al.
Publicado: (2017)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

RET/PTC and CK19 Expression in Papillary Thyroid Carcinoma and Its Clinicopathologic Correlation
por: Shin, Eunah, et al.
Publicado: (2005)

Radiomic prediction models for the level of Ki-67 and p53 in glioma
por: Sun, Xiaojun, et al.
Publicado: (2020)

The prognostic significance of p63 and Ki-67 expression in myoepithelial carcinoma
por: Jiang, You-Hua, et al.
Publicado: (2012)

Expression and Clinical Significance of Ki67 and SOX2 in Colorectal Cancer
por: Hu, Bo, et al.
Publicado: (2023)

Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade
por: Burger, M, et al.
Publicado: (2007)

The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines
por: Subik, Kristina, et al.
Publicado: (2010)

Prognostic significance of CEA, Ki67 and p53 in pseudomyxoma peritonei of appendiceal origin
por: Yan, Fengcai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_72okvf3cmoj9ptfe293mbsgu1n